Franz X. Vollenweider
University Hospital of Psychiatry
Neuropsychopharmacology and Brain Imaging & Heffter Research Center
Lenggstrasse 31
CH-8032 Zürich
Switzerland
Name/email consistency: high
- The effects of the preferential 5-HT2A agonist psilocybin on prepulse inhibition of startle in healthy human volunteers depend on interstimulus interval. Vollenweider, F.X., Csomor, P.A., Knappe, B., Geyer, M.A., Quednow, B.B. Neuropsychopharmacology (2007)
- Clozapine enhances prepulse inhibition in healthy humans with low but not with high prepulse inhibition levels. Vollenweider, F.X., Barro, M., Csomor, P.A., Feldon, J. Biol. Psychiatry (2006)
- MDMA affects both error-rate dependent and independent aspects of decision-making in a two-choice prediction task. Vollenweider, F.X., Liechti, M.E., Paulus, M.P. J. Psychopharmacol. (Oxford) (2005)
- Acute psychological and neurophysiological effects of MDMA in humans. Vollenweider, F.X., Liechti, M.E., Gamma, A., Greer, G., Geyer, M. J. Psychoactive. Drugs (2002)
- A systems model of altered consciousness: integrating natural and drug-induced psychoses. Vollenweider, F.X., Geyer, M.A. Brain Res. Bull. (2001)
- Effects of (S)-ketamine on striatal dopamine: a [11C]raclopride PET study of a model psychosis in humans. Vollenweider, F.X., Vontobel, P., Oye, I., Hell, D., Leenders, K.L. J. Psychiatr. Res (2000)
- Opposite effects of 3,4-methylenedioxymethamphetamine (MDMA) on sensorimotor gating in rats versus healthy humans. Vollenweider, F.X., Remensberger, S., Hell, D., Geyer, M.A. Psychopharmacology (Berl.) (1999)
- Effects of high amphetamine dose on mood and cerebral glucose metabolism in normal volunteers using positron emission tomography (PET). Vollenweider, F.X., Maguire, R.P., Leenders, K.L., Mathys, K., Angst, J. Psychiatry. Res (1998)
- Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG). Vollenweider, F.X., Leenders, K.L., Scharfetter, C., Antonini, A., Maguire, P., Missimer, J., Angst, J. Eur. Neuropsychopharmacol (1997)









